Get CEO.CA Pro
Real-time Level 2 Market Depth
Click for live demo
back
news releases
19 Apr 2018, 08:00
Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives $ARGS
Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives $ARGS
2 Apr 2018, 08:30
Argos Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights $ARGS
Argos Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights $ARGS
28 Mar 2018, 17:00
Argos Therapeutics to Report Fourth Quarter and Year-End 2017 Financial Results and Operational Highlights on Monday, April 2, 2018 $ARGS
Argos Therapeutics to Report Fourth Quarter and Year-End 2017 Financial Results and Operational Highlights on Monday, April 2, 2018 $ARGS
15 Feb 2018, 08:30
Argos Announces Issuance of Patent Covering the Foundation for Manufacturing its HIV Immunotherapy $ARGS
Argos Announces Issuance of Patent Covering the Foundation for Manufacturing its HIV Immunotherapy $ARGS
show more ▾
featured articles
April 19, 2024
Welcome To The Metalsverse, We're Just Getting Started!
Welcome To The Metalsverse, We're Just Getting Started!
April 18, 2024
Drilling Confirms 4 km of Favourable Corridor at Lynx Gold Trend $PUMA $PUXPF.US $PUMXF.US
Drilling Confirms 4 km of Favourable Corridor at Lynx Gold Trend $PUMA $PUXPF.US $PUMXF.US
April 18, 2024
Arizona Metals Intersects 20.1 m at 3.4% CuEq (incl. 3.2 m at 14.9% CuEq) and 38.0 m at 1.4% CuEq (incl. 4.4 m at 7.1% CuEq) in Kay Mine Expansion Drilling $AMC $AZMCF.US
Arizona Metals Intersects 20.1 m at 3.4% CuEq (incl. 3.2 m at 14.9% CuEq) and 38.0 m at 1.4% CuEq (incl. 4.4 m at 7.1% CuEq) in Kay Mine Expansion Drilling $AMC $AZMCF.US
April 17, 2024
WonderFi Appoints Jaime Leverton and Noel Biderman to its Board of Directors $WONDF.US $WNDR $52D0 $CA97818W1077
WonderFi Appoints Jaime Leverton and Noel Biderman to its Board of Directors $WONDF.US $WNDR $52D0 $CA97818W1077
show more ▾
CEO.CA Chairman's Briefing
Global Markets. Mining Trends. Every Thursday.
read first
Please read the CEO.CA House Rules before posting.
social
legal
Use of this site indicates acceptance of the
Privacy Policy
and
Terms of Use.
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.
© 2022 - CEO.CA Technologies Ltd.
Argos Therapeutics, Inc.
ARGS
$ARGS ↻
0 online
Today
This week
Search
Subscribe
Sign up to become a contributing member of the community.
Trending
Personal channels
